Internal Medicine, Nephrology · Spartanburg, SC
NPI
1689654071
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
322 N Pine St
Spartanburg, SC, 29302
Phone (864) 582-5099
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
2,478 services
Medicare patients, 2024
618
Average age 75
Drug cost, 2024
$1.2M
4,324 prescriptions
Company payments, 2025
$1,740
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad Y Ebrahim was code 99214 (office e&m - established), 911 times for 416 patients. In total Muhammad Y Ebrahim billed 2,478 services in 25 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 911 | 416 | $86.30 | $79K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 609 | 351 | $12.27 | $7,471 |
| 99232 Hospital E&M - Subsequent | Facility | 362 | 131 | $58.18 | $21K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 193 | 106 | $41.83 | $8,073 |
| 99204 Office E&M - New | Office | 81 | 81 | $112.05 | $9,076 |
| 99233 Hospital E&M - Subsequent | Facility | 59 | 44 | $87.34 | $5,153 |
| 99222 Hospital E&M - Initial | Facility | 51 | 47 | $97.40 | $4,967 |
| 99223 Hospital E&M - Initial | Facility | 43 | 41 | $128.07 | $5,507 |
| 99213 Office E&M - Established | Office | 40 | 31 | $66.44 | $2,658 |
| 99215 Office E&M - Established | Office | 29 | 25 | $116.63 | $3,382 |
| 99205 Office E&M - New | Office | 23 | 23 | $158.40 | $3,643 |
| 90935 Hemodialysis | Facility | 17 | 15 | $52.86 | $899 |
By year: 2022 $138K for 1,785 services; 2023 $140K for 1,785 services; 2024 $155K for 2,478 services.
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad Y Ebrahim prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 436 prescriptions and refills. In total Muhammad Y Ebrahim wrote 4,324 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 436 | 604 | 103 | $333K |
| Prazosin Hcl Generic | 371 | 765 | 130 | $8,145 |
| Jardiance Empagliflozin | 210 | 280 | 46 | $164K |
| Nebivolol Hcl Generic | 191 | 351 | 62 | $7,520 |
| Kerendia Finerenone | 190 | 238 | 42 | $150K |
| Bumetanide Generic | 184 | 383 | 79 | $5,179 |
| Spironolactone Generic | 171 | 381 | 55 | $1,704 |
| Carvedilol Generic | 148 | 378 | 58 | $1,460 |
| Amlodipine Besylate Generic | 146 | 370 | 62 | $880 |
| Potassium Chloride Generic | 103 | 229 | 34 | $2,710 |
| Ozempic Semaglutide | 99 | 119 | 22 | $106K |
| Furosemide Generic | 92 | 226 | 35 | $608 |
| Tamsulosin Hcl Generic | 87 | 223 | 31 | $1,214 |
| Repaglinide Generic | 84 | 145 | 21 | $1,296 |
| Eplerenone Generic | 74 | 153 | 26 | $8,497 |
Brand drugs: - claims; generic drugs: 3,116 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad Y Ebrahim $1,740 ($1,740 in general payments such as food, travel and fees) from 21 companies. The largest payer was Travere Therapeutics, Inc. with $272.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 17 | $272 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 27 | $217 |
| Calliditas Therapeutics US Inc. | 7 | $197 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $118 |
| Amgen Inc. AMGN | 6 | $117 |
| Akebia Therapeutics Inc AKBA | 3 | $87.94 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $78.18 |
| Novo Nordisk Inc NVO | 4 | $75.22 |
| Scpharmaceuticals Inc. SCPH | 3 | $74.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.